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tissue regeneration, stem cell–based 
therapy has been recognized as a prom-
ising therapeutic option, due to their 
versatile differentiation capacity and bio-
activity.[4,5] As a kind of multipotent cells, 
mesenchymal stem cells (MSCs) retain 
their potential of self-renewal and can dif-
ferentiate into multiple kinds of cell types 
under suitable microenvironments.[6] As 
a type of mesenchymal stem cells, bone 
marrow MSC (BMSC) is considered to be 
an ideal candidate for bone tissue regen-
eration.[7–9] However, in recent years, more 
attention has been given to the promotion 
of osteogenesis in adipose-derived stem 
cells (ADSCs).[10] As compared to BMSCs, 
ADSCs have numerous advantages, 
including abundant sources, ease of isola-
tion, and a higher propensity to be accepted 
by patient.[11] The regulation of the osteo-
genic differentiation of ADSCs is rather 
essential for their clinical applications in 
the bone tissue regenerative medicine.[12,13]
Various bioactive factors such as miRNA and protein/pep-
tide have been employed to treat diseases and enhance the oste-
ogenic differentiation of BMSCs/ADSCs.[14–17] However, the 
bioactive factors usually show several disadvantages including 
high cost and low stability.[18] Relative to conventional bioac-
tive factors, recently bioactive materials, which can efficiently 
Adipose-derived stem cells (ADSCs) are considered to be ideal stem cell 
sources for bone-tissue regeneration owing to their ease of collection 
and high activity. However, the regulation of osteogenic differentiation of 
ADSCs using biomaterials without adding growth factors is still not satis-
factory. For the first time, molybdenum-doped bioactive glass nanoparti-
cles with a radial porous morphology (Mo-rBGNs) are reported and their 
role in the osteogenic differentiation of ADSCs is investigated. The results 
show that Mo-rBGNs exhibit radially porous and spherical morphology, 
relatively homogeneous particle size (200–400 nm), and excellent apatite-
forming bioactivity. They do not affect the proliferation of ADSCs, but 
significantly regulate their osteogenic differentiation and biomineraliza-
tion. 5% Mo-rBGNs significantly enhance the alkaline phosphatase activity 
and biomineralization ability and promote the osteogenic gene expressions 
of collagen I secretion and bone sialo protein in ADSCs. A reasonable and 
promising strategy for designing nanoscale bioactive materials with the 




Due to the growing trauma, disease, and aging of population, 
bone tissue defect has been a relatively common clinical dis-
ease.[1] There was increasing requirement for biomaterials to 
replace/repair/restore the bone tissue.[2,3] In the field of bone 
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regulate the cell behavior and tissue regeneration, have been 
developed through their optimized design for the structure-
composition.[19–22] The bioactive materials were also developed 
for improving the osteogenic differentiation of stem cells.[23–25] 
For example, bioactive silicate-based biomaterials and bioac-
tive glasses (BGs) have shown their inherent osteogenic dif-
ferentiation ability for both BMSCs and ADSCs.[26,27] BGs have 
become one of the best bioactive materials for bone regenera-
tion in recent years, due to their biocompatibility, osteoinduced 
ability, and controlled degradation, as well as bone-bonding 
activity.[28–34] Recent studies showed that bioactive materials 
with nanostructure demonstrated the enhanced capacity for 
enhancing soft/hard tissue regeneration in vitro and in vivo.[35–38] 
It was very necessary to develop novel nanoscale bioactive mate-
rials for stimulating the osteogenic differentiation of ADSCs.
In previous studies, our group developed several monodis-
persed bioactive glass nanoparticles (BGNs) for biomedical 
applications including bioimaging, gene/drug delivery, and 
osteogenic differentiation of stem cells.[39–42] For example, 
monodispersed BGNs possessed inherent enhanced osteo-
genic differentiation ability for BMSCs and osteoblasts in vitro, 
as well as reinforced bone tissue regeneration in vivo.[43] Our 
previous study first showed that monodispersed BGNs could 
enhance the osteogenic differentiation of ADSCs through acti-
vating the TGF-Beta/Smad 3 signaling pathway.[44] In addition, 
the metallic elements, such as Cu, Sr, and Gd, showed their 
special biological functions including stimulation of osteo-
genesis and angiogenesis, as well as antitumor activity.[45–47] 
Previous study found that europium-doped BGNs (Eu-BGNs) 
significantly enhanced the osteogenic differentiation of human 
BMSCs.[48] However, europium is not the essential element of 
human body and probably difficult to be cleared in renal, which 
has increased the concerns regarding the long-term toxicity. 
The effect of metallic elements–doped BGNs on the osteogenic 
differentiation of ADSCs is few reported.
By contrast, molybdenum is known to be readily absorbed 
from the intestinal tract and excreted mainly in the urine.[49] 
Molybdenum is also very important for the normal metabolism 
of life as a necessary trace element of organisms.[50] Further-
more, recent studies showed that molybdenum may be related 
to the growth of bone and tooth.[51] Therefore, it may be very 
promising to investigate the molybdenum-doped BGNs 
(Mo-BGNs) as a bioactive material for regulating osteogenic dif-
ferentiation of ADSCs.
In this study, we synthesize the branched monodispersed 
Mo-rBGNs with a radial porous structure and investigate their 
potential application in regulating the osteogenic differen-
tiation of ADSCs. The physicochemical structure, biominer-
alization activity, cytotoxicity, as well as the effects on cellular 
mineralization, alkaline phosphatase activity (ALP), osteogenic 
protein, and gene expressions of ADSCs for Mo-rBGNs, were 
investigated.
2. Results and Discussion
2.1. Synthesis and Characterizations of Mo-rBGNs
In this work, to demonstrate the osteogenic differentiation 
effect of functionalized monodispersed BGNs, Mo-doped radial 
bioactive glass nanoparticles (Mo-rBGNs) were developed by a 
modified sol–gel method (Figure 1). The osteogenic activity of 
Mo-rBGNs was evaluated by detecting its effect on regulating 
the cellular biomineralization and expressions of osteogenic 
gene in ADSCs.
The physicochemical structure characterizations of 
Mo-rBGNs samples are shown in Figure 2. The as-prepared 
Mo-rBGNs exhibited a radially spherical morphology and a 
uniform diameter of 300–400 nm (Figure 2a–h; Figure S1, 
Supporting Information). As shown in transmission electron 
microscope (TEM) images (Figure 2e–h), the Mo incorporation 
did not produce effect on the size of Mo-BGNs, but the 
morphology was significantly tight upon the increase of Mo 
content, indicating the increase of Mo-complexes in glass 
network. The mean hydrodynamic diameters of 0Mo-rBGNs, 
2Mo-rBGNs, 5Mo-rBGNs, and 10Mo-BGNs were about 308, 
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Figure 1. Schematic illustration describing the synthetic route of Mo-rBGNs and their potential biomedical applications in vitro and in vivo.
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330, 320, and 423 nm with Zeta potentials of −10.4, −7.26, −7.13, 
and −4.89 mV, respectively (Figure 2i). The morphology and ele-
ment composition of Mo-rBGNs were also analyzed by high 
resolution scanning electron microscopy (SEM) (Figure 2j,k). 
The energy dispersive spectra (EDS) mapping of 10Mo-rBGNs 
showed that Si and Mo were evenly distributed within the whole 
nanoparticles (Figure S2, Supporting Information). The EDS 
analysis confirmed that the detected Mo/Si molar ratio resulted 
in fair agreement with the theoretical ratio (Figure 2l–o). Addi-
tionally, as the increase of the intensity of Mo peak, the calcium 
(Ca) decreased because Ca was substituted by Mo complexes 
in the glass compositions. Such findings indicate that Mo was 
incorporated in the silicate structure of the glasses.
The phase structure and chemical structure of xMo-BGNs 
were further analyzed by X-ray diffraction (XRD), Fourier-trans-
form infrared spectroscopy (FTIR), and X-ray photoelectron 
spectroscopy (XPS) (Figure 3). In the XRD patterns of 
Mo-rBGNs (Figure 3a), the broad peak at 23° was corre-
sponded to amorphous silica, and the diffraction peaks at 
2θ = 18.6°, 28.8°, 31.2°, 34.3°, 47.1°, 49.3°, and 58.0° were 
attributed to (101), (112), (004), (200), (204), (220), and (312) 
reflections of CaMoO4 (JCPDS 29-0351). The above anal-
yses suggest that the phase structure of Mo-rBGNs was 
significantly affected by the addition of Mo. As shown in 
FTIR (Figure 3b), the bands located at around 860, 898, 
and 1000 cm−1 were assigned to the bending vibration of 
SiOSi, the asymmetrical stretching mode of MoOMo, 
and the symmetrical stretching mode SiOSi, respectively. 
Moreover, the presence of a band at around 1631 cm−1  
was caused by the OH groups in water molecules. The charac-
teristic bands of SiOSi were significantly weakened upon the 
increase of Mo content, indicating the decrease of glass network 
integrity and the appearance of molybdenum phase. The XPS 
analysis showed that surface of 10Mo-BGNs was composed of 
Ca, O, Si, and Mo elements (Figure 3c) and the typical XPS two-
peak shape of Mo 3d spectrum could be observed (Figure 3d). 
This pair of strong peaks located at 231.2 and 234.5 eV could be 
attributed to the Mo6+. These results demonstrated that mono-
dispersed Mo-rBGNs with uniform size was synthesized suc-
cessfully by the ultrasonic assisted template technique.
2.2. Biomineralization Activity Analysis of Mo-rBGNs
In order to explain the bone-bonding ability and osteogenic bio-
activity of Mo-rBGNs, the samples were soaked into simulated 
body fluids (SBF) for various times to evaluate the biological 
apatite-forming ability (biomineralization activity). After immer-
sion in SBF for 1 d, the structure and morphology of Mo-rBGNs 
were not significantly changed (Figure 4a–c; Figure S3, Sup-
porting Information). After further soaking in SBF, the XRD 
diffraction patterns (Figure 4d) of Mo-rBGNs demonstrated 
peaks at ≈31.7°, 36.4°, 45.4°, and 56.6° which corresponded to 
the lattice planes (112), (202), (222), and (211) of hydroxyapa-
tite (HA) (JCPDS 09-0432). And two characteristic peaks at 
596 and 604 cm−1 corresponding to the PO bands in PO43− 
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Figure 2. Morphology evaluation of Mo-rBGNs. a–d) TEM images of 0Mo-rBGNs a), 2Mo-rBGNs b), 5Mo-rBGNs c), and 10Mo-rBGNs d) (scale bar: 
200 nm); e–h) high magnification TEM pictures (scale bar: 100 nm); i) Zeta-potential analysis (*p < 0.05; **p < 0.01); j) SEM image of 10Mo-rBGNs 
(scale bar: 1 µm); k) EDS mapping of 10Mo-rBGNs (scale bar: 1 µm); l–o) EDS spectra of 0Mo-rBGNs, 2Mo-rBGNs, 5Mo-rBGNs, and 10Mo-rBGNs.
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of crystalline CaP were seen in the FTIR spectra (Figure 4e) 
after soaking for 3 d. These new peaks of FTIR spectra and XRD 
patterns became significantly stronger upon the increase of 
the soaking time (Figure 4g,h). Additionally, after soaking Mo-
rBGNs in SBF for 3 and 7 d, TEM demonstrated that the depos-
ited apatite layer possessed a flake-like morphology which was 
the typical morphology of hydroxyapatite (Figure 4f,i; Figures S4 
and S5, Supporting Information). In summary, the above results 
confirmed the apatite-forming ability of Mo-rBGNs implying 
their possible bone-bonding capability in vivo and Mo incorpo-
ration did not affect the excellent biomineralization of BGNs.
2.3. Cellular Biocompatibility Evaluation
ADSCs were employed as the model to analyze the cellular 
biocompatibility of Mo-rBGNs. After incubation with samples 
(40–200 µg mL−1), ADSCs exhibited good cell attachment mor-
phology (Figure 5a; Figure S6, Supporting Information). Specif-
ically, as shown in Figure 5a, after treatment with nanoparticles 
at 80 µg mL−1 for 72 h, significantly higher numbers of living 
cells (green fluorescence) were observed as compared with 
Blank, demonstrating that samples at this safe concentration 
could support cell growth. However, at the high particle con-
centration (120 and 200 µg mL−1), poor attachment mor-
phology was observed between different Mo-rBGNs groups and 
Blank. These results indicated that the suitable concentration 
of Mo-rBGNs could improve cell proliferation. In addition, at 
day 1, Mo-rBGNs with 40 µg mL−1 demonstrated significantly 
higher cell viability compared to that of Blank. The cell viability 
showed a significant decrease upon the increase of concen-
tration (Figure 5b). Notably, the relative cell viability values of 
5Mo-rBGNs showed that the cells could efficiently proliferate 
after culture for 72 h with nanoparticles at a concentration 
of 40–80 µg mL−1 (Figure 5c). Our results demonstrated that 
Mo-rBGNs with specific Mo content at a safe concentration 
could efficiently enhance cellular biocompatibility which may be 
a great benefit to their application of osteogenic differentiation.
2.4. Osteogenic Differentiation Analysis
The ALP activity and mineralized nodule formation are an early-
stage marker for osteogenic differentiation and a phenotypic 
marker for mature osteoblasts. The ALP activities measured in 
ADSCs following incubation with Mo-rBGNs (30–90 µg mL−1) 
Part. Part. Syst. Charact. 2019, 36, 1900105
Figure 3. Characterizations of Mo-rBGNs. a,b) XRD patterns a) and FTIR spectra b) of Mo-rBGNs; c) XPS spectrum of 10Mo-rBGNs; d) Mo 3d peaks 
in XPS spectra of 10Mo-rBGNs.
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under osteoinductive conditions were detected at days 7 and 
14. Figure 6a,b shows that the relative ALP activities in all sam-
ples were significantly increased with culture times. On day 7, 
for 2Mo-rBGNs and 5Mo-rBGNs, the ALP activities were sig-
nificantly increased with increasing particle concentration, 
with no significant differences observed between other groups. 
After incubation with Mo-rBGNs from 30–90 µg mL−1 for 14 d, 
the ALP activities were all higher than Blank. These results 
showed that low-content Mo (2 and 5 mol%)-doped rBGNs 
with suitable concentration could effectively enhance the ALP 
activity of ADSCs. The calcium deposition and mineralization 
of Mo-rBGNs were detected by alizarin red stain and relative 
intensity calcium-content examination (Figure 6c,d). Compared 
with Blank, Mo-rBGNs groups with concentration of 60 µg mL−1 
demonstrated significantly stronger alizarin red staining after 
a 21 d incubation, suggesting positive calcium mineraliza-
tion (Figure 6c). The relative gray intensity of calcium-content 
detection in ADSCs was performed following treatment with 
different concentrations of materials for 21 d (Figure 6d). We 
observed that the relative gray intensity of calcium content 
was significantly enhanced by incubation with 5Mo-rBGNs of 
60 µg mL−1 relative to the Blank; however, there were no signifi-
cant difference in calcium content between the different con-
centration groups on day 21 (Figure 6d; Figure S2, Supporting 
Information). The results from alizarin red staining and rela-
tive gray intensity of calcium-content analysis suggested that 
the optimized Mo-doped rBGNs significantly improved miner-
alization capability of ADSCs.
To demonstrate the effect of Mo-rBGNs at the concentration 
of 60 µg mL−1 on the osteogenic differentiation of ADSCs at 
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Figure 4. Biomineralization activity evaluation of Mo-rBGNs. a–c) XRD patterns a), FTIR spectra b) of Mo-rBGNs, and TEM image c) of 10Mo-rBGNs 
after biomineralization for 1 d (scale bar: 100 nm); d–f) XRD patterns d), FTIR spectra e) of Mo-rBGNs, and TEM image f) of 10Mo-rBGNs after 
biomineralization for 3 d (scale bar: 100 nm); g–i) XRD patterns g), FTIR spectra h) of Mo-rBGNs, and TEM image i) of 10Mo-rBGNs after biominer-
alization for 7 d (scale bar: 100 nm).
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the mRNA level, we determined the expressions of early-stage 
osteoblastic marker genes (Col I) and late-stage marker (Bsp) 
in cells after culture for various periods (Figure 7). The Col I 
expression on day 7 was first upregulated after incubation 
with Mo-BGNs at a low-content Mo-doped and followed by 
the decreased at 5Mo-rBGNs (Figure 7a). On day 14, no sig-
nificant difference of Col I expression among various groups 
was observed (Figure 7b). For Bsp expression, on days 7 and 
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Figure 6. In vitro ALP activity evaluation and calcium deposition biomineralization staining evaluation of ADSCs following induction by Mo-rBGNs. 
a,b) ALP activity on day 7 a) and day 14 b) (*p < 0.05; **p < 0.01); c) the relative gray intensity based on the images of alizarin red staining; d) alizarin 
red staining of ADSCs (*p < 0.05; **p < 0.01).
Figure 5. Cellular biocompatibility evaluation of ADSCs following incubation with various concentrations of Mo-rBGNs. a) Fluorescence images 
indicating live–dead staining after a 3 d incubation (scale bar: 100 µm); b,c) cell viability and proliferation after culture for 1 d b) to 3 d c) (*p < 0.05; 
**p < 0.01). The solution without nanoparticle was used as the negative control (Blank).
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900105 (7 of 10)
www.advancedsciencenews.com
www.particle-journal.com
Part. Part. Syst. Charact. 2019, 36, 1900105
14, 2Mo-rBGNs group with 60 µg mL−1 showed the signifi-
cantly high Bsp level, as compared with Blank and other groups 
(Figure 7c,d; Figure S7, Supporting Information). These results 
suggested that the Mo-rBGNs could dramatically enhance the 
osteogenic genes expression in ADSCs.
Additionally, the immunofluorescence staining for Col I and 
Bsp proteins on day 21 were investigated to demonstrate the 
continuity effect of Mo-rBGNs on ADSCs osteogenic proteins 
expression. Col I and Bsp were shown, respectively, as green 
and red while nuclei were stained as blue. Both of early- and 
late-stage proteins in Blank groups expressed no obvious posi-
tive Col I and Bsp staining (Figure 8a). However, the signifi-
cant fluorescence intensity associated with Col I expression 
continued to increase from 0 to 5 mol% of Mo-doped rBGNs, 
reaching peak values at 5 mol% (Figure 8b). Under the same 
osteoinductive condition, the Bsp protein expression showed a 
similar tendency with the positive Col I protein staining and 
5Mo-rBGNs showed observably higher fluorescence intensity 
associated with Bsp expression comparing with other groups 
(Figure 8c). The ALP activity, alizarin red staining, osteogenic 
genes analysis, and immunofluorescence staining further dem-
onstrated that Mo-rBGNs could efficiently enhance the osteo-
genic differentiation of ADSCs.
3. Conclusion
In summary, monodispersed Mo-rBGNs were fabricated by 
an ultrasonic assisted template method. Mo-rBGNs showed a 
uniform spherical porous morphology with a particle size of 
300–400 nm. The Mo-rBGNs could efficiently induce the for-
mation of biological apatite layer under SBF environment, indi-
cating their excellent biomineralization activity. Our Mo-rBGNs 
significantly enhanced the osteogenic differentiation of ADSCs 
through improving their ALP activity, calcium mineralization, 
osteogenic proteins, and gene expressions. This study first 
suggests that the rBGNs with low content Mo doping could 
effectively enhance the biomineralization and osteogenic differ-
entiation of ADSCs, suggesting their great potential for ADSC-
based bone tissue regeneration.
4. Experimental Section
Synthesis of Monodispersed Mo-rBGNs: Monodispersed Mo-rBGNs 
was prepared by incorporating Mo into the BGNs framework to replace 
role of calcium through an ultrasonic assisted sol–gel method. Briefly, 
7.5 mL cyclohexane was added into a solution composed of 0.15 g 
urea, 0.23 g isopropanol, 0.25 g cetylpyridinium bromide, and 7.5 mL 
of deionized water under continuous stirring at room temperature. 
The mixture was allowed to react for 2 h prior to the addition of 
0.675 mL tetraethyl orthosilicate (TEOS). Under vigorous stirring of 
30 min, the reactants were heated to 70 °C and were allowed to react 
for 7 h. Then appropriate amounts of series of reagents were added 
in the following sequence: TEP, Ca(NO3)2⋅4H2O, H8MoN2O4, allowing 
30 min for each reagent to react completely. After a further stirring 
of 16 h, the suspension was centrifuged at 10 000 rpm for 15 min to 
collect deposits, which were further washed thrice with acetone, twice 
with ethanol, and twice with water. Finally, these deposits were dried 
by a freeze-drying before calcination at 650 °C for 10 h at a heating 
rate of 1 °C min−1 under air conditions. The designed compositions 
of Mo-rBGNs were 60SiO2:(36−x)CaO:4P2O5:xMo in mol% (x = 0, 2, 
5, or 10) and designated as 0Mo-rBGNs, 2Mo-rBGNs, 5Mo-rBGNs, 
Figure 7. Relative expression of osteoblastic marker gene during osteogenic differentiation following induction by Mo-rBGNs with 60 µg mL−1 on 
day 7 and 14. a,b) Relative expression of Col I a) and Bsp b) on day 7; c,d) relative expression of Col I c) and Bsp d) on day 14. *p < 0.05; **p < 0.01.
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and 10Mo-rBGNs, accordingly. The types and sources of chemicals are 
shown in the Supporting Information.
Physicochemical Structure Characterizations of Mo-rBGNs: The 
morphology and particle size of the Mo-rBGNs were analyzed using a 
transmission electron microscope (JEOL JEM-F200) working at 100 kV. 
The phase analysis of samples was examined by X-ray diffractometer 
(D/MAX-RB, Rigaku) with a Ni-filtered Cu Kα irradiation at 40 kV and 
30 mA. The elemental composition of samples was determined by 
energy dispersive X-ray analysis (Quanta 250 FEG, FEI). The infrared 
spectra of the samples were obtained using a Fourier transformer 
infrared spectrophotometer (Nicolet 6700), in a wave number range of 
400–4000 cm−1. The analyses of surface element type and atom valance 
were performed using X-ray photoelectron spectroscopy (Thermo Fisher 
ESCALAB Xi+). The surface charge of Mo-rBGNs was characterized using 
ζ-potential measurement on a Zetasizer Nano ZS (Nano-ZS, Malvern) 
instrument operating with a dynamic light scattering detector positioned 
at 90° and the test samples were suspended in 3 mL deionized water at 
a concentration of 1 mg mL−1.
Biomineralization Activity Assessment of Mo-rBGNs: In vitro 
biomineralization activity was evaluated through the methodology 
described in the previous report where the protocol for the assessment of 
hydroxyapatite forming ability of bioactive glass particles is proposed.[39] 
The structure and composition of formed hydroxyapatite on the surface 
of Mo-rBGNs was identified through XRD, FTIR, and TEM respectively. 
The detailed procedure is shown in the Supporting Information.
In Vitro Cellular-Biocompatibility Assessment of Mo-rBGNs: Adipose-
derived stem cells (Cellbank, Shanghai) were used to investigate the 
in vitro cellular biocompatibility of Mo-rBGNs. ADSCs were obtained 
from ATCC (American Type Culture Collection). The cytotoxicity and cell 
viability of Mo-rBGNs were studied by the alamar blue assay kit (Thermo 
Fisher Scientific). The morphology and attachment of cells were also 
determined following LIVE/DEAD assay kit (Invitrogen). These testing 
procedures were according to the manufacturer’s instructions. The 
Supporting Information shows the detailed description for cell culture, 
alamar blue, and LIVE/DEAD analysis.
Cellular Biomineralization and Osteogenic Differentiation Analysis: The 
alizarin red stain (Genmed) assay was used to indicate the results of 
calcium deposition and extracellular-matrix mineralization of ADSCs. 
After incubation with differentiation medium including Mo-rBGNs in 
24-well plates at a density of 2 × 104 cells mL−1 for 14 and 21 d, cells 
were fixed for 20 min using 4% paraformaldehyde, washed by PBS, and 
stained by 200 µL alizarin for 24 h at room temperature. The stained 
cells were captured by a fluorescence microscope (IX53, Olympus). 
Finally, the calcium content of the differentiated ADSCs induced by 
Mo-rBGNs was calculated as the relative gray intensity of cells.
As an early marker of osteogenic differentiation, the ALP activities of 
ADSCs were evaluated on days 7, 14, and 21, using the SensoLyte pNPP 
ALP assay (AnaSpec), according to the manufacturer’s instructions. The 
detailed procedure can be found in the Supporting Information. The 
immunofluorescence staining of osteogenic proteins (Col I and Bsp 
proteins) were assessed on 21 d. The methods and procedures were 
similar with previous report with little change (Supporting Information). 
The quantitative real-time polymerase chain reaction (qRT-PCR) 
technique was employed to validate the expression patterns of 
osteogenic genes including Col I and Bsp. The primers for qRT-PCR are 
shown in Table S1 in the Supporting Information. And the procedures 
including the extraction of total RNA and analysis of qRT-PCR are 
indicated in the Supporting Information.
Statistical Analysis: The experiments were tested at least in triplicate 
and all data were expressed as the value mean ± standard deviation 
Figure 8. Immunofluorescence staining for the Col I and Bsp proteins in ADSCs on day 21 after being incubated with 60 µg mL−1 Mo-rBGNs. a) Immu-
nofluorescent staining of Col I and Bsp proteins (scale bar: 100 µm); b) relative fluorescent intensity of Col I protein (*p < 0.05; **p < 0.01); c) relative 
fluorescent intensity of Bsp protein (*p < 0.05; **p < 0.01).
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(SD) (n = 5 per group). The statistical analyses were assessed by the 
SPSS software (version 13.0). The Student’s t-test analysis of variance 
was employed to determine the significant differences between 
different groups. *p < 0.05 and **p < 0.01 were counted statistically 
significant.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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